Fig. 4: Overall survival stratified by EGFR expression status.

a Kaplan–Meier estimates in patients without erlotinib treatment by EGFR expression status. b Kaplan–Meier estimates in patients treated with erlotinib by EGFR expression status. HR hazard ratio.